These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8614070)

  • 21. Effects of granulocyte-colony stimulating factor on the polymorphonuclear leukocyte activity and the course of sepsis in rats with experimental peritonitis.
    Gurleyik G; Yanikkaya G; Gurleyik E; Ozturk E; Dulundu E; Saglam A
    Surg Today; 2007; 37(5):401-5. PubMed ID: 17468822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-center, real-world experience with granulocyte colony-stimulating factor for management of leukopenia following kidney transplantation.
    Hamel S; Kuo V; Sawinski D; Johnson D; Bloom RD; Bleicher M; Goral S; Lim MA; Trofe-Clark J
    Clin Transplant; 2019 Jun; 33(6):e13541. PubMed ID: 30887581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Granulocyte colony stimulating factor in the treatment of alcohol abuse, leukopenia, and pneumococcal sepsis.
    Grimsley EW
    South Med J; 1995 Feb; 88(2):220-1. PubMed ID: 7530862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte colony-stimulating factor prophylaxis improves survival and inflammation in a two-hit model of hemorrhage and sepsis.
    Bauhofer A; Lorenz W; Kohlert F; Torossian A
    Crit Care Med; 2006 Mar; 34(3):778-84. PubMed ID: 16521271
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary report: rhG-CSF may reduce the incidence of neonatal sepsis in prolonged preeclampsia-associated neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1998 Nov; 102(5):1107-11. PubMed ID: 9794941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized, placebo-controlled trial of granulocyte colony-stimulating factor administration to newborn infants with neutropenia and clinical signs of early-onset sepsis.
    Schibler KR; Osborne KA; Leung LY; Le TV; Baker SI; Thompson DD
    Pediatrics; 1998 Jul; 102(1 Pt 1):6-13. PubMed ID: 9651406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Granulocyte colony stimulating factor (G-CSF) in treatment of patients with HIV-associated mucocutaneous Kaposi sarcoma. Successful use in virus and drug-induced leukopenia].
    Schröder K; Garbe C; Waibel M; Reupke H; Detmar M; Dallenbach F; Orfanos CE
    Hautarzt; 1992 Nov; 43(11):700-6. PubMed ID: 1281810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Hematopoietic growth factors in prevention and therapy of infectious complications in premature and newborn infants].
    Lehrnbecher T
    Z Geburtshilfe Neonatol; 2001; 205(5):167-73. PubMed ID: 11727663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Deleterious effects of mild hypothermia in septic rats are ameliorated by granulocyte colony-stimulating factor.
    Torossian A; Ruehlmann S; Middeke M; Sessler DI; Lorenz W; Wulf HF; Bauhofer A
    Anesthesiology; 2003 Nov; 99(5):1087-92. PubMed ID: 14576544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of granulocyte and granulocyte-macrophage colony-stimulating factors in the induction treatment of adult acute lymphoblastic leukemia: a multicenter randomized study.
    Thomas X; Boiron JM; Huguet F; Reman O; Sutton L; Turlure P; Garban F; Gardin C; Espinouse D; Boulat O; Lhéritier V; Fiere D;
    Hematol J; 2004; 5(5):384-94. PubMed ID: 15448664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of recombinant human granulocyte colony-stimulating factor in patients receiving chemotherapy for urogenital cancer. Urological rhG-CSF Study Group.
    Aso Y; Akaza H
    J Urol; 1992 Apr; 147(4):1060-4. PubMed ID: 1372661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical study of recombinant human granulocyte colony stimulating factor (rhG-CSF) on leukopenia induced by chemotherapy in cancer patients].
    Shi YK; Zhou JC; Feng FY
    Zhonghua Zhong Liu Za Zhi; 1994 May; 16(3):207-10. PubMed ID: 7525173
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effectiveness of hemopoietic growth factors in sepsis].
    Yilmaz G; Aldemir M; Yilmaz R; Diken H; Büyükbayram H; Akgün Y
    Ulus Travma Derg; 2001 Apr; 7(2):82-6. PubMed ID: 11705042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study on acupuncture for leukopenia induced by chemotherapy].
    Han YF; Gong Z; Huang LQ; Xia X; Zhao WJ
    Zhongguo Zhen Jiu; 2010 Oct; 30(10):802-5. PubMed ID: 21058473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of granulocyte colony-stimulating factor on functional and histopathologic outcome after traumatic brain injury in mice.
    Sheibani N; Grabowski EF; Schoenfeld DA; Whalen MJ
    Crit Care Med; 2004 Nov; 32(11):2274-8. PubMed ID: 15640641
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Granulocyte-colony stimulating factor and clinical laboratory].
    Orita T; Kitamura K; Ohkubo A
    Rinsho Byori; 1993 Apr; 41(4):372-6. PubMed ID: 7688831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human granulocyte-macrophage colony-stimulating factor (rHuGM-CSF) in leukopenic patients with advanced HIV disease.
    Manfredi R; Mastroianni A; Coronado O; Chiodo F
    J Chemother; 1996 Jun; 8(3):214-20. PubMed ID: 8808719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The increase of the rate of hemopoietic recovery and clinical benefit of the erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF) with peripheral blood progenitor cells (PBPC) after intensive cyclic chemotherapy in high-risk breast cancer patients.
    Filip S; Vanásek J; Bláha M; Mericka P; Vávrová J; Podzimek K
    Neoplasma; 1999; 46(3):166-72. PubMed ID: 10613592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.